TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma
Pavla Brachova(University of Iowa), Kimberly K. Leslie(University of New Mexico)
Cited by 97
Related Papers
EGFR isoforms and gene regulation in human endometrial cancer cells
|Molecular Cancer|2010|56
Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment
|PLoS ONE|2011|54
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer
|Cancers|2025|12
Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targets
|The Journal of Steroid Biochemistry and Molecular Biology|2023|2